A new treatment for bladder cancer, combining enfortumab vedotin with pembrolizumab, has been approved for use by the NHS in England. This therapy ...
New research published in Nature Communications reveals that certain breast cancer tumors may utilize neighboring fat cells as an energy source, po...
Recent advancements in cancer immunology have identified phagocytosis checkpoints, such as the CD47/SIRPα axis, which play a crucial role in tumor ...
10x Genomics has launched Xenium Protein, a new addition to its Xenium Spatial platform, enabling simultaneous RNA and protein detection in the sam...
Recent research published in the journal 'Nature' has revealed that common respiratory viruses, such as COVID-19 and the flu, can reactivate dorman...
Anixa Biosciences has announced the treatment of the second patient in the fourth cohort of its Phase 1 clinical trial for a novel CAR-T therapy ta...
Recent research has highlighted the role of the ubiquitin ligase APC/C in coordinating cell cycle progression by targeting proteins for degradation...
Anixa Biosciences has treated the second patient in the fourth cohort of its Phase 1 clinical trial for ovarian cancer CAR-T therapy. The trial, co...
A recent study has examined the long-term survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who rel...
Phil Knight, co-founder of Nike, along with his wife Penny, has donated $2 billion to the Oregon Health & Science University (OHSU) to support the ...